Anterior Cruciate Ligaments: Studying Updates in neuroCognition After Knee Manipulation
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Jun 30, 2025
Trial Information
Current as of July 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a treatment called knee joint manipulation can help improve brain and muscle function in people who have had surgery to repair a torn anterior cruciate ligament (ACL) in the knee. The ACL is an important ligament that helps keep your knee stable, and after surgery, some people may have slower reaction times or difficulty with movement. The study will look at how this treatment affects reaction times and movement skills by testing participants before and after the knee manipulation.
People who might be eligible to join are between 18 and 35 years old, had ACL surgery between 4 months and 5 years ago, and are active in sports or physical activities with their injured knee. They must also show some delay in reaction time compared to typical averages and have been cleared by a doctor to participate. If chosen, participants will complete a series of simple tests that measure how quickly and accurately they respond to visual cues and how well they perform certain hopping tasks, both before and after receiving the knee manipulation treatment. This study aims to see if adding knee manipulation to rehabilitation is practical and if it could help improve brain and muscle coordination after ACL surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Provided informed consent prior to any study procedures that are performed.
- • Are between the ages of 18 and 35.
- • Have undergone ACLR surgery. All autograft and allograft types are accepted.
- • Are 4-months to 5-years post-ACLR.
- • Injured knee playing or training for sports (recreational or organized) or during physical activity.
- • Have been cleared by a physician to return to activities and/or participate in this study.
- • Are at least the minimally clinical important difference (MCID) above the normative reaction time average for our methods as established by previous literature in at least 1 reaction time task.
- Exclusion Criteria:
- • History of concussion in the past 3 months.
- • The participant is pregnant.
- • Have a neurological disorder, including epilepsy.
- • Currently injured or have injured their lower extremity in the past 3 months.
- • Had surgery on multiple ligaments when their ACL was injured.
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Shelby Baez, PhD, ATC
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported